SynthesisThe oncologist2024

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis.

Shi-Jia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.